Companies / Apogee Therapeutics, Inc.
Apogee Therapeutics, Inc.
Nasdaq: APGECIK 1974640SAN FRANCISCO, CA
Financials
Ownership
75.7M shares outstanding · as of Aug 3, 2026
Ownership
Share classes
| Common Stock | 82.18% | |
| Common Stock | 17.82% |
| Insiders | 2.38% | 1,799,503 |
| 10%+ / strategic | 8.21% | 6,213,827 |
| Institutions | 89.98% | 68,104,721 |
| Public float | 0.00% | 0 |
Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 8
View all →| Insider | % of shares | Shares |
|---|---|---|
Henderson Michael ThomasCEOChief Executive Officer · Director | 1.52% | 1,152,987 |
Fairmount Funds Management LLCDirector | 0.39% | 298,647 |
Henderson JaneChief Financial Officer | 0.24% | 179,371 |
Dambkowski CarlChief Medical Officer | 0.22% | 168,498 |
| — | — | |
Harwin Peter EvanDirector | — | — |
Jones William a JrDirector | — | — |
Kiselak TomasDirector | — | — |
Institutional holders 224
View all →| Holder | Value | % of shares |
|---|---|---|
| $730.95M | 7.28% | |
| $641.08M | 11.22% | |
| $620.83M | 10.87% | |
| $358.27M | 6.27% | |
| $304.98M | 3.04% | |
| $215.71M | 3.78% | |
| $204.71M | 3.58% | |
| $198.81M | 3.12% | |
| $164.83M | 2.89% | |
| $154.63M | 2.71% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | — | $228.70M | +1.7M +45.53% | 5,507,032 7.28% of shares | high |
| Q2 2026 as of | State Street Corporation 13F manager | Add | — | $80.64M | +608K +35.95% | 2,297,743 3.04% of shares | high |
| Q1 2026 as of | Perceptive Advisors LLC 13F manager | Trim | — | $-66.52M | -790K -33.91% | 1,540,384 2.04% of shares | high |
| Q4 2025 as of | Barclays PLC 13F manager | Trim | — | $-38.43M | -509K -79.26% | 133,193 0.18% of shares | medium |
| Q1 2026 as of | Balyasny Asset Management L.P. 13F manager | New | — | $36.92M | +439K | 438,654 0.58% of shares | medium |
| Q4 2025 as of | Bank of America Corp /De 13F manager | Add | — | $30.18M | +400K +101.49% | 793,695 1.05% of shares | medium |
| Q1 2026 as of | Federated Hermes Inc 13F manager | Add | — | $26.50M | +315K +246.08% | 442,738 0.58% of shares | medium |
| Q1 2026 as of | Janus Henderson Group PLC 13F manager | Add | — | $25.10M | +298K +14.45% | 2,360,596 3.12% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| Vanguard Group Inc | Passive13G | — |
| RTW Investments, LP | Passive13G/A | — |
| T. Rowe Price Investment Management, Inc. | Passive13G | — |
| Wellington Management Group LLP | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| APGE | — | 03770N101 |